Evidence map›Paper›PMID 22022577›Full record

ArticlePloS one2011

Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.

Yu-Yin Shih, Hsinyu Lee, Akira Nakagawara, Hseuh-Fen Juan, Yung-Ming Jeng, Yeou-Guang Tsay, Dong-Tsamn Lin, Fon-Jou Hsieh, Chien-Yuan Pan, Wen-Ming Hsu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention.Frontiers in cell and developmental biology · 2022
    Review
  3. The regulation of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor β signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Yu-Yin ShihLaboratory of Molecular Neurobiology, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Hsinyu Lee
Akira Nakagawara
Hseuh-Fen Juan
Yung-Ming Jeng
Yeou-Guang Tsay
Dong-Tsamn Lin
Fon-Jou Hsieh
Chien-Yuan Pan
Wen-Ming Hsu
Yung-Feng Liao
National Taiwan University · TWNational Taiwan University Hospital · TWChiba Cancer Center · JPInstitute of Cellular and Organismic Biology, Academia Sinica · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoic acid (RA) has been approved for the differentiation therapy of neuroblastoma (NB). Previous work revealed a correlation between glucose-regulated protein 75 (GRP75) and the RA-elicited neuronal differentiation of NB cells. The present study further demonstrated that GRP75 translocates into the nucleus and physically interacts with retinoid receptors (RARα and RXRα) to augment RA-elicited neuronal differentiation. GRP75 was required for RARα/RXRα-mediated transcriptional regulation and was shown to reduce the proteasome-mediated degradation of RARα/RXRαin a RA-dependent manner. More intriguingly, the level of GRP75/RARα/RXRα tripartite complexes was tightly associated with the RA-induced suppression of tumor growth in animals and the histological grade of differentiation in human NB tumors. The formation of GRP75/RARα/RXRα complexes was intimately correlated with a normal MYCN copy number of NB tumors, possibly implicating a favorable prognosis of NB tumors. The present findings reveal a novel function of nucleus-localized GRP75 in actively promoting neuronal differentiation, delineating the mode of action for the differentiation therapy of NB by RA.

Indexed as

Cell DifferentiationAnimalsCell NucleusDown-RegulationGene DosageHSP70 Heat-Shock ProteinsHumansMembrane ProteinsMiceNeuroblastomaNeuronsN-Myc Proto-Oncogene ProteinNuclear ProteinsOncogene ProteinsProteasome Endopeptidase ComplexProtein Bindingglucose-regulated proteinsHSP70 Heat-Shock ProteinsMembrane ProteinsMYCN protein, humanN-Myc Proto-Oncogene ProteinNuclear ProteinsOncogene ProteinsProteasome Endopeptidase ComplexReceptors, Retinoic AcidTretinoin

Identifiers

PMID22022577
PMCPMC3194821
OpenAlexW2060456288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.